MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on June 10, 2004; DOI: 10.1124/mol.104.001503


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.001503v1
66/3/387    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hartz, A. M.S.
Right arrow Articles by Miller, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hartz, A. M.S.
Right arrow Articles by Miller, D. S.


Received for publication April 16, 2004.
Revised June 3, 2004.
Accepted for publication June 3, 2004.

RAPID REGULATION OF P-GLYCOPROTEIN AT THE BLOOD-BRAIN BARRIER BY ENDOTHELIN-1

Anika M.S. Hartz 1, Bjorn Bauer 1, Gert Fricker 2, David S. Miller 1*

1 National Institute of Environmental Health Sciences 2 University of Heidelberg

* Address correspondence to: E-mail: miller{at}niehs.nih.gov

Abstract

The ATP-driven xenobiotic transporter, p-glycoprotein, is a critical element of the blood-brain barrier. To study regulation of p-glycoprotein function, we measured specific transport (PSC833-sensitive) of a fluorescent cyclosporine A derivative (NBDL-CSA) into the lumens of isolated rat brain capillaries using confocal microscopy and quantitative image analysis. Luminal NBDL-CSA accumulation was rapidly and reversibly reduced in a concentration-dependent manner by 0.1-100 nM endothelin-1 (ET-1). In this concentration range, ET-1 did not affect junctional permeability. The ETB receptor agonist, sarafotoxin 6c, also reduced transport. Effects of ET-1 and sarafotoxin 6c were blocked by an ETB receptor antagonist; an ETA receptor antagonist was without effect. Consistent with this, immunostaining and Western blotting showed expression of the ETB receptor in brain capillary membranes. NBDL-CSA transport was also reduced by sodium nitroprusside (SNP), a NO donor, and by phorbol ester, a protein kinase C (PKC) activator. Inhibition of NO synthase (NOS) or PKC abolished the ET-1 effects. Thus, ET-1, acting through an ETB receptor, NOS and PKC, rapidly and reversibly reduced transport mediated by p-glycoprotein at the blood-brain barrier.


Key words: Endothelin, Nitric oxide, Protein Kinase C, MDR/p-Glycoprotein, Fluorescence techniques





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics